KSQ-4279, a first-in-class USP1 inhibitor shows strong combination activity in BRCA mutant cancers with intrinsic or acquired resistance to PARP inhibitors

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2022-10, Vol.174, p.S37-S38
Main Authors: Cadzow, L., Gokhale, P.C., Ganapathy, S., Sullivan, P., Nayak, S., Shenker, S., Schlabach, M., Tobin, E., Matulonis, U.A., Liu, J.F., Stegmeier, F., Wylie, A.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(22)00900-5